UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Invacare Corporation of Class Action Lawsuit and the Deadline of July 23, 2013 to Seek a Lead Plaintiff Position

NEW YORK, NY--(Marketwired - Jun 27, 2013) - Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Ohio on behalf of investors who purchased Invacare Corporation ("Invacare" or the "Company") (NYSE: IVC) stock between July 22, 2010 and December 7, 2011.

For more information, click here: http://zlk.9nl.com/invacare/. 

The Complaint alleges that during the Class Period, Invacare and certain of its senior executives issued false and misleading press releases, financial statements, filings with the Securities and Exchange Commission ("SEC"), and statements during investor conference calls. In particular, it is alleged that Invacare masked the fact that the Company suffered from widespread operational, quality, and regulatory deficiencies, and concealed that it received a series of warnings from the FDA-- known as Forms 483--which identified serious compliance violations at its two major United States-based manufacturing facilities.

On December 8, 2011, Invacare acknowledged that the FDA intended to enter a consent decree, which would require the suspension of certain operations until the Company's manufacturing facilities became compliant with FDA regulations. Upon this news, Invacare stock fell more than 28% to close at $14.70 per share.

If you suffered a loss in Invacare you have until July 23, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (877) 363-5972, or visit http://zlk.9nl.com/invacare/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.